B
13.97
0.03 (0.22%)
| Penutupan Terdahulu | 13.94 |
| Buka | 13.90 |
| Jumlah Dagangan | 1,459,732 |
| Purata Dagangan (3B) | 1,122,933 |
| Modal Pasaran | 615,024,128 |
| Harga / Jualan (P/S) | 4.29 |
| Harga / Buku (P/B) | 1.64 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 17 Feb 2026 |
| Margin Keuntungan | -101.62% |
| Margin Operasi (TTM) | -105.69% |
| EPS Cair (TTM) | -1.64 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 36.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2.22% |
| Nisbah Semasa (MRQ) | 15.88 |
| Aliran Tunai Operasi (OCF TTM) | -56.10 M |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | Beta Bionics, Inc. | Menurun | Menurun |
AISkor Stockmoo
-0.9
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | -1.0 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | -0.90 |
|
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 6.51% |
| % Dimiliki oleh Institusi | 98.41% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 40.00 (Lake Street, 186.33%) | Beli |
| Median | 23.50 (68.22%) | |
| Rendah | 14.00 (Baird, 0.22%) | Pegang |
| Purata | 25.17 (80.17%) | |
| Jumlah | 4 Beli, 2 Pegang | |
| Harga Purata @ Panggilan | 17.59 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Baird | 18 Feb 2026 | 14.00 (0.21%) | Pegang | 13.61 |
| Stifel | 18 Feb 2026 | 22.00 (57.48%) | Beli | 13.61 |
| 04 Feb 2026 | 25.00 (78.95%) | Beli | 14.09 | |
| Truist Securities | 02 Feb 2026 | 25.00 (78.95%) | Beli | 13.70 |
| 18 Dec 2025 | 37.00 (164.85%) | Beli | 29.06 | |
| TD Cowen | 27 Jan 2026 | 17.00 (21.69%) | Pegang | 14.93 |
| Lake Street | 09 Jan 2026 | 40.00 (186.33%) | Beli | 20.14 |
| B of A Securities | 05 Jan 2026 | 33.00 (136.22%) | Beli | 29.57 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| FEIDER STEPHEN | 12.63 | 12.52 | 130,115 | 1,643,510 |
| HOPMAN MARK | 12.63 | 11.95 | 107,918 | 1,363,537 |
| MENSINGER MIKE | 12.63 | 12.52 | 108,041 | 1,364,675 |
| RUSSELL STEVEN JON | 12.63 | 12.52 | 108,079 | 1,365,151 |
| SAINT SEAN | 12.63 | 12.52 | 339,885 | 4,293,120 |
| Jumlah Keseluruhan Kuantiti Bersih | 794,038 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 10,029,992 | |||
| Purata Pembelian Keseluruhan ($) | 12.63 | |||
| Purata Jualan Keseluruhan ($) | 12.33 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| HOPMAN MARK | Pegawai | 04 Mar 2026 | Jual automatik (-) | 353 | 11.38 | 4,017 |
| MENSINGER MIKE | Pegawai | 02 Mar 2026 | Jual (-) | 1,064 | 12.52 | 13,321 |
| FEIDER STEPHEN | Pegawai | 02 Mar 2026 | Jual (-) | 1,428 | 12.52 | 17,879 |
| SAINT SEAN | Pegawai | 02 Mar 2026 | Jual (-) | 3,384 | 12.52 | 42,368 |
| RUSSELL STEVEN JON | Pegawai | 02 Mar 2026 | Jual (-) | 1,026 | 12.52 | 12,846 |
| HOPMAN MARK | Pegawai | 02 Mar 2026 | Jual (-) | 834 | 12.52 | 10,442 |
| MENSINGER MIKE | Pegawai | 27 Feb 2026 | Diperolehi (+) | 109,105 | 12.63 | 1,377,996 |
| FEIDER STEPHEN | Pegawai | 27 Feb 2026 | Diperolehi (+) | 131,543 | 12.63 | 1,661,388 |
| SAINT SEAN | Pegawai | 27 Feb 2026 | Diperolehi (+) | 343,269 | 12.63 | 4,335,487 |
| RUSSELL STEVEN JON | Pegawai | 27 Feb 2026 | Diperolehi (+) | 109,105 | 12.63 | 1,377,996 |
| HOPMAN MARK | Pegawai | 27 Feb 2026 | Diperolehi (+) | 109,105 | 12.63 | 1,377,996 |
| Papar semua | ||||||
| Tarikh | Jenis | Butiran |
|---|---|---|
| 15 Jan 2026 | Pengumuman | Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 |
| 08 Jan 2026 | Pengumuman | Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |